Chest wall irradiation does not impact 10-year survival in intermediate-risk breast cancer

Patients with intermediate-risk breast cancer had similar rates of 10-year overall survival whether or not they underwent chest wall irradiation (CWI) after mastectomy, according to results from the BIG 2-04 MRC SUPREMO clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.

FDA accepts Orexo’s NDA for opioid overdose medication

Share this article OX124 is a high-dose rescue medication for opioid overdose. Credit: Orexo. The US Food and Drug Administration (FDA) has accepted Orexo’s new

November 28, 2023

With sweeping NIH reform on the table, GOP previews new era of research scrutiny

WASHINGTON — There seems to be broad agreement that change is coming for the National Institutes of Health. It is just a matter of how

June 18, 2024

Automated system enhances stroke rehabilitation using robots

The increasing number of strokes and subsequent rehabilitation has highlighted the growing need for effective care strategies.

December 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.